Thromb Haemost 1981; 46(04): 687-689
DOI: 10.1055/s-0038-1653453
Original Article
Schattauer GmbH Stuttgart

HLA Antigens and Factor VIII Antibody in Classic Hemophilia

European Study Group of Factor VIII Antibody
D Frommel
The Participating Centers: I.N.S.E.R.M. U 56 & Clinique de Pédiatrie Université Paris-Sud, Bicêtre
,
J P Allain
Internats médico-pédagogiques pour Jeunes hémophiles de la Croix Rouge franҫaise, Centre Air & Soleil
,
E Saint-Paul
Centre E. Rémigy
,
C Bosser
Centre I’Espoir, France
,
B Noël
Centre I’Espoir, France
,
P M Mannucci
Ospedale Policlinico, Milano
,
F Pannicucci
Spedali Riuniti di San Chiara, Pisa, Italy
,
M Blombäck
Karolinska Sjukhuset, Stockholm, Sweden
,
O Prou-Wartelle
Tissue Typing Laboratories, Centre National de Transfusion Sanguine, Paris
,
J Y Muller
Tissue Typing Laboratories, Centre National de Transfusion Sanguine, Paris
› Author Affiliations
Further Information

Publication History

Received 04 April 1981

Accepted 14 September 1981

Publication Date:
05 July 2018 (online)

Summary

Possible interrelations between the immune response factor VIII and the major histocompatibility system were investigated in 57 multi-transfused hemophilic brothers belonging to 26 families. Linkage appears very unlikely although formal proof of independence cannot be offered. The HLA system, therefore, does not provide markers predictive for the development of antibodies to factor VIII in severe hemophilia A.

 
  • References

  • 1 Shapiro SS. Antibodies to blood coagulation factors. Clin Haematol 1979; 9: 207-214
  • 2 Frommel D, Allain JP. Genetic predisposition to develop factor VIII antibody in classic hemophilia. Clin Immunol Immunopath 1977; 8: 34-38
  • 3 Frommel D, Muller JY, Prou Wartelle O, Allain JP. Possible linkage between the major histocompatibility complex and the immune response to factor Vin in classic haemophilia. Vox Sang 1977; 33: 270-272
  • 4 Nunez-Roldan A, Amaiz-Villena A, Nunez-Ollero G. Contrôle génétique par la région HLA de la réponse immunitaire au facteur Vin chez les hémophiles. C R Acad Sc (Paris) 288 (série D) 1979; 1719-1720
  • 5 European Study group of factor VIII antibody. Development of factor VIII antibody in haemophilic monozygotic twins. Scand J Haematol 1979; 23: 64-68
  • 6 Allain JP, Frommel D. Antibodies to Factor VIII. V. Patterns of immune response to factor VIII in hemophilia A Blood 1976; 47: 973-982
  • 7 Terasaki PI, Bemoco D, Park MS, Ozturk G, Iwaki Y. Micro-droplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Path 1978; 69: 103-120
  • 8 Sultan Y, Maisonneuve P. Incidence des inhibiteurs du facteur Vin dans la population des hémophiles français. Nouv Ref fr Hémat 1977; 18: 671-673
  • 9 Ruggeri ZM. Natural history of 39 factor VIII inhibitors in hemophiliacs. In Workshop on inhibitors of factor VIII and factor IX p 45-49 Vienna: Facultas Verlag; 1976
  • 10 European Study Group of factor VIII antibody: Genetic aspects of inhibitor formation in hemophilia. In: Seligson U. (ed.) Haemophilia- Key issues; Castle House Publ London: 1977. pp 80-85
  • 11 Thomson G, Bodmer W. The genetic analysis of HLA and disease association. In: Dausset J, Svejgaard A. (eds.) pp 84-93 HLA and Disease Munksgaard, Copenhagen; 1977
  • 12 Haverkom MJ, Hofman B, Masurel N, van Rood JJ. HLA linked genetic control of immune response in man. Transpl Rev 1975; 22: 120-124
  • 13 Nelson PD, Pyke DA, Gamble DR. Viruses and the aetiology of diabetes: a study in identical twins. Br Med J 1975; 4: 249-251